ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...
Barré syndrome market is poised for substantial growth, fueled by advancements in treatment options, including intravenous immunoglobulin (IVIg), plasmapheresis, and emerging immunotherapies.
Background Acute upper gastrointestinal bleeding (AUGIB) is a common medical emergency with evolving demographics and ...
RSV infection in adults ≥65 is linked to rare but elevated Guillain-Barré syndrome risk, particularly in those aged ≥75 years ...
Vadodara: A young man who once lay motionless on a ventilator, trapped between life and death, is now walking again — the ...
In late summer, private landowners reported seeing the emaciated deer, which was euthanized and tested in September.
Team Casper dethroned the king of U.S. curling, John Shuster, and his supremely talented rink to become Olympic Trials ...
Neurological signs include stumbling showing a lack of coordination such as stumbling, weakness in the back limbs, loss of ...
CHICAGO — De novo autoimmune diseases, including myositis, vasculitis and lupus, may occur after chimeric antigen receptor ...
Histoplasmosis, blastomycosis, and coccidioidomycosis, which are often linked to contaminated soil, occur in different parts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback